BiomedicalPublications

Neuro-Oncology Advances

Oxford University Press·United Kingdom·ISSN 2632-2498

Open accessIn DOAJFee waivers availableMedicine

Cost to publish

$2,615

Open-access article processing charge, list price.

Time to publication

12 wks

Broadly typical for the field.

h-index

50

OpenAlex citation statistic. Not a Journal Impact Factor.

2-year mean citedness

1.0

Average citations to articles from the previous two years.

What it costs to publish here

Publishing an open-access article in Neuro-Oncology Advances is listed at $2,615. The journal reports that fee waivers are available — worth pursuing if you are funding this yourself or working from a lower-income country.

The journal's own fee page →

What this journal has charged over time

List price for an open-access article in Neuro-Oncology Advances, as recorded by OpenAlex for each year. The fee has risen 22% since 2021, from $2,142 to $2,615.

$0$1.4k$2.8k2021: $2,14220212022: $2,37120222023: $2,37120232024: $2,82420242025: $2,6152025

Publishers change list prices without notice and often apply discounts, institutional agreements or waivers. Treat this as the trend, and confirm the current figure with the journal.

Peer review and licensing

Review modelAnonymous peer review (policy)
LicenceCC BY, CC BY-NC
Author keeps copyrightNo
Plagiarism screeningNot reported
Editorial boardPublished →
LanguagesEN

Verification checks

7 of 8 confirmed

These are facts we could verify in public records, not a verdict. A journal missing a check is not necessarily disreputable — many long-established subscription journals sit outside the open-access registries entirely. Use them as questions to ask, and confirm anything that matters directly with the journal before you submit.

  • Listed in the Directory of Open Access JournalsDOAJ applies a documented set of inclusion criteria.
  • Included in OpenAlex's curated core setOpenAlex flags well-established venues that appear across major indexes.
  • Peer review model publicly declaredAnonymous peer review
  • Publication charges stated up frontA journal that will not tell you the fee before submission is worth a second look.
  • Screens submissions for plagiarismReported to DOAJ by the journal.
  • Participates in a digital preservation schemeArchiving means the record survives if the publisher does not.
  • Assigns persistent identifiers (DOIs)Standard practice; its absence is unusual.
  • Still actively publishingMost recent indexed article: 2026.

Scope

The subjects Neuro-Oncology Advances publishes most, derived from the topics assigned to its indexed articles.

Glioma Diagnosis and TreatmentBrain Metastases and TreatmentMeningioma and schwannoma managementRadiomics and Machine Learning in Medical ImagingLung Cancer Research StudiesNeurofibromatosis and Schwannoma CasesCancer, Hypoxia, and MetabolismRadiopharmaceutical Chemistry and ApplicationsNeuroblastoma Research and TreatmentsLung Cancer Treatments and Mutations

Publication record

Indexed articles3,902
Total citations16,249
i10-index489
Most recent indexed article2026
Open access since2019
All ISSNs2632-2498

Counts reflect what OpenAlex has indexed and will differ from the publisher's own figures. We do not show a founding year: OpenAlex's first-publication dates are distorted by mis-dated records — it puts PLoS ONE in 1806 — and we would rather omit a number than print one we cannot stand behind.